PTCT

#1188
PTC Therapeutics, Inc.
73.01 USD
+3.68%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
73.01
73.01
Rango anual
35.95
87.50
Cambio diario
+3.68%
Variación mensual
+12.70%
Variación en los últimos 6 meses
+10.91%
Cambio anual
+63.01%
Cierres anteriores
70.42
Abrir
73.01
Bid
Ask
Mínimo
73.01
High
73.01
Volumen
222
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

PTC Therapeutics Inc

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Noticias